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In vivo microbiome and associated 
immune markers: New insights 
into the pathogenesis of vaginal 
dysbiosis
Giuseppina Campisciano1, Nunzia Zanotta1, Danilo Licastro2, Francesco De Seta3,4 &  
Manola Comar1,3
The microbiota fulfils a key role in the training and function of the immune system, which contributes 
to the symbiosis between the host and complex microbial communities. In this study, we characterized 
the interplay between vaginal bacteria and local immune mediators during dysbiosis in selected women 
of reproductive age who were grouped according to Nugent’s criteria. The abundance of Gardnerella 
vaginalis and Bifidobacterium breve was increased in the intermediate dysbiotic status, while the 
presence of a plethora of non-resident bacteria characterized the group with overt vaginosis. In 
response to these increases, the anti-inflammatory IL1ra and pro-inflammatory IL2 increased, while the 
embryo trophic factors FGFβ and GMCSF decreased compared to the healthy milieu. A specific pattern, 
including IL1α, IL1β, IL8, MIG, MIP1α and RANTES, distinguished the intermediate group from the 
vaginosis group, while IL5 and IL13, which are secreted by Th2 cells, were significantly associated 
with the perturbation of the commensals Lactobacilli, Gardnerella and Ureaplasma. Summarizing, we 
postulate that although the dysbiotic condition triggers a pro-inflammatory process, the presence of 
a steady state level of Th2 may influence clinical manifestations. These results raise clinically relevant 
questions regarding the use of vaginal immunological markers as efficacious tools to monitor microbial 
alterations.
The female reproductive tract harbours a symbiotic community that consists of host cells and bacterial commu-
nities1. Perturbation of the vaginal microbiota is associated with a large spectrum of urogenital diseases that affect 
many aspects of woman’s lives, including fertility and acquisition of sexually transmitted infections2–5. Indeed, 
the vaginal mucosa is susceptible to the entry of pathogens, where both local immune mediators and commensal 
microorganisms are the first line of host defence6–8.
Bacterial vaginosis (BV) is the most common vaginal dysmicrobism, diagnosed in 20–30% of women of 
reproductive age, with a prevalence of 50–60% in some high-risk sexual behaviour populations9. BV is caused by 
a reduction of the commensal Lactobacillus spp., elevated pH and a concomitant overgrowth of several strict or 
facultative anaerobic bacteria10. Thus, BV is a polymicrobial disease11–13 in which a single pathogen is not able to 
induce the disease. The predominance of Lactobacillus spp., as well as the presence of other lactic acid-producing 
bacteria, appears to be pivotal to counteract the growth of BV-associated bacteria and to reduce the susceptibility 
to other infections14–16.
Although approximately half of BV cases are clinically asymptomatic17, an increase of local pro-inflammatory 
effectors has been observed in women with BV18,19. Recent studies have reported the existence of biotic signals 
that are conducive to a vaginal protective function20. In this network, cytokines are interspecies communication 
molecules that coordinate the interactions of vaginal communities, including the growth of pathogenic microorgan-
isms21,22. However, the clinical impact of the modulation of cytokines on vaginal dysbiosis remains to be elucidated.
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We profiled the vaginal microbiome and the local immune fluctuation in selected women of reproductive 
age grouped according to the Nugent’s criteria with the goal of investigating the role of local immune mediators 
during the vaginal dysbiotic process.
In women with an intermediate Nugent score, we observed that the overgrowth of Gardnerella vaginalis was 
balanced by a high colonization of Bifidobacterium breve, which, overall, was able to guarantee a healthy vaginal 
equilibrium. Conversely, in women with BV, we observed a massive increase of non-resident vaginal species that 
paralleled a low presence of G. vaginalis.
The local immune response of the host was specifically stimulated by the vaginal dysbiosis, with a simultane-
ous increase of the anti-inflammatory IL1ra and the pro-inflammatory IL2 and a decrease of the embryo trophic 
factors FGFβ and GMCSF. Moreover, a specific pattern of mediators, including IL1α, IL1β, IL8, MIG, MIP1α and 
RANTES, distinguished the grade of vaginal dysbiosis observed in women with an intermediate Nugent score and 
in women with overt vaginosis.
Among the tested immune mediators, a significant association of the modulation of specific resident bacterial 
communities was highlighted for IL5 and IL13. The increase in the concentration of these two anti-inflammatory 
proteins was accompanied by a depletion of Lactobacilli ssp., G. vaginalis and Ureaplasma spp. The concomi-
tant increase of the anti-inflammatory IL5 and IL13, secreted by Th2 cells, and the establishment of a vaginal 
dysmicrobism suggests a role for the Th2 activation in counteracting the Th1 response and in counteracting the 
presence of clinical symptoms.
Results
Characterization of women with vaginal dysbiosis. To characterize the vaginal dysbiotic process, we 
collected 62 cervical-vaginal samples from women who were diagnosed according to Nugent’s criteria, includ-
ing 30 women with a Nugent score of 0–3 (Healthy), 15 women with Nugent score of 4–6 (Intermediate) and 
17 women with Nugent score of 7–10 (Vaginosis). The sequencing of the vaginal microbial community yielded 
3,496,234 high-quality reads, excluding samples with less than 10,000 reads, with an average of 53,788 reads/
sample (range 10,531–190,162). We identified 15,769 operational taxonomic units (OTUs) across all the samples.
Bacterial diversity and comparisons of alpha diversity between cohorts. Out of the five distinct 
alpha diversity metrics (within-sample diversity), the Simpson, Shannon, observed species and PD_whole_tree 
metrics significantly characterized the dysbiotic vaginal microbiome (Table 1) from that of the healthy microbi-
ome, while Chao1 did not exhibit significant variations. Overall, across the five metrics used, the intermediate and 
vaginosis groups showed higher alpha diversities than the healthy group.
When accounting for the bacterial communities in the cohorts (Fig. 1), the intermediate and vaginosis groups 
showed more heterogeneity among Lactobacilli species when compared to the healthy group.
Healthy women exhibited three predominant Lactobacilli species, namely L. acidophilus, L. crispatus and L. 
iners (Firmicutes), which were underrepresented in the intermediate and vaginosis groups. L. gasseri was the most 
abundant Lactobacillus in the intermediate group, while L. iners was the dominant Lactobacillus species in the 
vaginosis group.
Among the other microorganisms detected, the intermediate group showed an increase of Gardnerella vag-
inalis (Actinobacteria) and Ureaplasma parvum (Tenericutes) compared to the vaginosis and healthy groups. 
Bifidobacterium breve was only detected in the intermediate group.
The vaginosis cohort exhibited a vast change in specific species, which are shown in Table 2.
We assessed which OTUs were discriminative between cohorts, and significant differences of bacterial species 
were not observed according to the FDR p value.
We next compared the overall microbial diversity between groups using the unweighted and weighted UniFrac 
distance matrices. The results of the β-diversity (between sample diversity comparison) were visualized by a 
Principal Coordinates Analysis (PCoA). As expected, the bacterial composition of these vaginal communities 
clustered according to the clinical grouping. Indeed, the analysis of the β-diversity highlights three distinct micro-
bial clusters in the unweighted UniFrac PCoA (Fig. 2). The same clustering is partially confirmed by the weighted 
UniFrac PCoA (Fig. 3), although it is graphically less evident.
A one-way Analysis of Similarity (ANOSIM) statistical test was applied to the UniFrac distance matrices to 
test for significant differences according to the clinical grouping. ANOSIM attributed a significant difference 
to the grouping, shown by the weighted UniFrac (p = 0.001) and unweighted UniFrac (p = 0.001) measures, 
Healthy Intermediate Vaginosis p values
Chao1 400.86 ± 110.87 498.94 ± 147.60 431.37 ± 128.93 0.051; 0.54; 1
Simpson 1.54 ± 0.56 3.55 ± 1.83 3.63 ± 2.270 0.003; 0.003; 1
Shannon 1.25 ± 0.6 2.52 ± 0.86 2.51 ± 0.87 0.003; 0.003; 1
Observed species 154.54 ± 43.08 214.06 ± 49.49 203.17 ± 53.14 0.003; 0.009; 1
PD whole tree 8.36 ± 1.31 10.03 ± 1.56 9.75 ± 1.99 0.003; 0.03; 1
Table 1. Comparison of bacterial diversity between cohorts. Bacterial diversity values are given as the 
mean ± standard deviation at a rarefaction depth of 10,000 sequences per sample. Alpha diversity was compared 
between groups by means of a non-parametric t-test using the compare_alpha_diversity.py script of QIIME. The 
p values are shown in the last column in the following order: Healthy vs Intermediate, Healthy vs Vaginosis, and 
Intermediate vs Vaginosis.
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although the ability of the clinical grouping to explain the differences between cohorts is small (R = 0.31 and 0.21, 
respectively).
Correlations between microbiome and immune soluble factors. Forty-eight soluble immune medi-
ators, including cytokines, chemokines and growth factors, were measured in the vaginal samples to address the 
local immune response to microbial changes, the results of which are shown in Table 3. We observed that an 
increase of the anti-inflammatory IL1ra and the pro-inflammatory IL2, and a decrease of the embryo trophic 
factors FGFβ and GMCSF, distinguished the dysbiotic from the eubiotic microbiomes.
A specific pattern of soluble immune mediators distinguished the grade of vaginal dysmicrobism. Specifically, 
a significant decrease of the proteins IL3, LIF, SCF, TNFβ, MCP1 and IL17 was associated with the intermediate 
group compared to the healthy group (Table 3). A significant increase of IL18, MIF and TNFα characterized the 
vaginosis group compared to the healthy group (Table 3). In addition, a panel of cytokines, including IL1α, IL1β, 
IL8, MIG, MIP1α and RANTES, exclusively differentiated the vaginal inflammatory process of the women who 
were diagnosed with an intermediate dysmicrobism from those with vaginosis (Table 3).
To evaluate the possible relationship between the local immune response and the bacterial composition, the 
concentrations of each immune factors were included as variables in the BIO-ENV rank-correlation procedure, 
where single variables or combinations of variables are selected based on how they best explain differences among 
samples.
Figure 1. The vaginal bacterial communities from patients with eubiotic and dysbiotic microbiota. The output 
of plot_taxa_summary.py of QIIME showing the relative abundance of the 33 predominant bacterial taxonomic 
groups, in alphabetical order, in the studied cohorts: Healthy (Nugent score 0–3), Intermediate (Nugent score 
4–6) and Vaginosis (Nugent score 7–10).
BV associated-bacteria
A. christensenii (Firmicutes)
A. fermentans (Firmicutes)
A. omnicolens (Fusobacteria)
A. vaginae (Actinobacteria)
BVAB1
C. braakii (Gammaproteobacteria)
D. micraerophilus (Firmicutes)
E. fergusonii (Gammaproteobacteria)
F. magna (Firmicutes)
K. granulomatis (Gammaproteobacteria)
P. bivia (Bacteroidia)
P. disiens (Bacteroidia)
P. timonensis (Bacteroidia)
S. anginosus (Firmicutes)
S. cohnii (Firmicutes)
S. massiliensis (Firmicutes)
S. pasteuri (Firmicutes)
S. simiae (Firmicutes)
V. montpellierensis (Firmicutes)
Table 2. BV associated-bacteria. Bacterial identities that were uniquely identified in the Vaginosis cohort.
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Based on the weighted UniFrac distance matrix, several immune factors showed a high correlation with the 
different microbial patterns observed among samples. In the dysbiotic microbiota, many of the significantly 
upregulated cytokines, such as IL18, IL2, IL1ra, MIF, RANTES, TNFα, MIP1α and IL8, were confirmed to cor-
relate with the alteration of the vaginal composition. Other immune factors, such as IL5, IL13, IL6, IL15, IL9, 
GROα, MIP1β and IFNγ, exhibited a correlation with the altered vaginal milieu, although their amount did not 
significantly change between cohorts.
Based on the unweighted UniFrac distance matrix, the soluble factors that correlated with the microbiome 
composition were MIF, IL18, MIP1β, TNFα and IL1ra (Table 4).
Figure 2. Unweighted UniFrac-based Principal Coordinates Analysis (PCoA). Unweighted UniFrac-based 
Principal Coordinates Analysis (PCoA) showing the clustering of bacterial communities according to the 
clinical grouping: Healthy (orange), Intermediate (red) and Vaginosis (blue). Each dot represents a sample. The 
Emperor PCoA plots were generated from the jackknifed_beta_diversity.py script of QIIME.
Figure 3. Weighted UniFrac-based Principal Coordinates Analysis (PCoA). Weighted UniFrac-based 
Principal Coordinates Analysis (PCoA) showing the clustering of bacterial communities according to the 
clinical grouping: Healthy (orange), Intermediate (red) and Vaginosis (blue). Each dot represents a sample. The 
Emperor PCoA plots were generated from the jackknifed_beta_diversity.py script of QIIME.
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Next, we explored whether any individual bacterium correlated with an increase or decrease of specific 
immune factors. The associations were performed after rarefying the otu_table_biom (depth 10,000 sequences) 
and using the observation_metadata_correlation.py script with the Fisher_z_transform.
Interleukin IL5 showed a significant correlation (FDR p < 0.01) with G. vaginalis, L. delbrueckii, L. acidophilus, 
L. johnsonii, L. gasseri, L. crispatus and L. iners, while IL13 was significantly (FDR p < 0.01) associated with G. 
vaginalis, L. delbrueckii, L. acidophilus, L. johnsonii, L. gasseri, L. crispatus, L. iners and U. parvum serovar 3. The 
association of other bacteria with the remaining analysed immune factors was not statistically significant when 
the p value was corrected for the false discovery rate (FDR).
Discussion
The use of high-throughput sequencing techniques shed new light on the high variability and complexity of the 
vaginal microbiome. Our in vivo results agree with recent studies that have shown that Nugent score, based on 
Healthy Intermediate Vaginosis
Healthy vs 
Intermediate
Healthy vs 
Vaginosis
Intermediate 
vs Vaginosis
cytokines
IL1α 62 ± 16 35 ± 6 295 ± 118 0.999 0.08 0.03
IL1β 43 ± 28 16 ± 7.5 215 ± 126 0.999 0.064 0.017
IL1ra 1.3E5 ± 2.5E4 3E5 ± 4.6E4 1.5E9 ± 1E9 0.014 0.000 0.605
IL2 1.4 ± 0.44 4.3 ± 0.6 4 ± 0.9 0.000 0.020 0.999
IL3 121 ± 9 87 ± 10 97 ± 10 0.028 0.277 0.999
IL17 12 ± 1.9 5 ± 0.5 7 ± 1 0.013 0.209 0.999
IL18 108 ± 21 216 ± 135 1373 ± 593 0.999 0.000 0.001
MIF 219 ± 113 780 ± 606 2353 ± 890 0.999 0.019 0.237
LIF 22 ± 1.3 12 ± 1.5 23 ± 2.7 0.000 0.999 0.002
SCF 23 ± 3.3 12 ± 2.8 18 ± 2.9 0.021 0.999 0.207
TNFα 14 ± 1.7 14 ± 2.3 31 ± 6 0.999 0.002 0.025
TNFβ 14 ± 1.8 9 ± 0.3 10 ± 0.6 0.013 0.999 0.271
chemokynes
IL8 157 ± 26 127 ± 45 351 ± 95 0.646 0.430 0.047
MCP1 9 ± 1.6 4.6 ± 0.5 5 ± 0.5 0.003 0.061 0.999
MIG 309 ± 119 188 ± 122 488 ± 178 0.08 0.999 0.016
MIP1α 1.7 ± 0.3 1.4 ± 0.4 2 ± 0.4 0.561 0.180 0.012
RANTES 11 ± 3.7 17 ± 12 24 ± 6 0.406 0.137 0.005
growth factors
FGFβ 32 ± 3 17 ± 1.2 18 ± 1.6 0.008 0.019 0.999
GMCSF 109 ± 4.5 81 ± 6.4 75 ± 4.6 0.015 0.000 0.593
Table 3. Significant variations in soluble immune factors. Data are shown as the mean value (pg/
mL) ± standard error of mean. Comparisons between groups were performed using a non-parametric Kruskal-
Wallis test. The p values are adjusted for multiple comparisons. Significant p values are highlighted in bold.
ρ (weighted UniFrac DM)
IL18 0.273 IL6 0.17
IL2 0.264 MIP1α 0.166
IL1ra 0.234 IL15 0.15
MIF 0.234 IL8 0.127
IL5 0.219 IL9 0.127
IL13 0.184 GROα 0.113
RANTES 0.175 MIP1β 0.112
TNFα 0.175 IFNγ 0.109
ρ (unweighted UniFrac DM)
MIF 0.243 TNFα 0.102
IL18 0.157 IL1ra 0.101
MIP1β 0.137 — —
Table 4. Output of the BIOENV rank-correlation procedure. Correlations between the 48 immune mediators 
and both weighted and unweighted UniFrac distance matrices are shown. The table shows the results for ρ ≥ 0.1. 
The results were generated from the beta_diversity.py output using the compare_categories.py script (metric 
BIOENV) of QIIME. Abbreviations: ρ: Spearman’s rank correlation coefficient; DM: distance matrix.
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the quantification of only three bacterial morphotypes, is not sufficiently informative to clearly define a vaginal 
dysbiotic status23.
Consistent with this issue is the observation of a high colonization by Bifidobacterium breve, neglected by 
Nugent Score, in the vaginal microbiome of women with an intermediate dysmicrobism. B. breve is able to coun-
teract the suboptimal colonization by the lactate-producing Lactobacilli spp.24, guaranteeing a healthy vaginal 
equilibrium through the same mechanism exploited by Lactobacilli, that is, the production of lactic acid. It is 
noteworthy that, by neglecting the presence of all lactate producing bacteria and the identification of Lactobacilli 
species, the Nugent score criteria led to the overestimation of the dysbiotic status and to an unnecessary thera-
peutic intervention being suggested.
In addition, the Nugent score neglects the dynamic of interspecies communication between specific species 
of Lactobacilli and opportunistic pathogens. In the group of healthy women, L. crispatus25 and L. acidophilus26 
inversely correlated with the presence of Gardnerella vaginalis, while in women with an intermediate Nugent 
Score, L. gasseri negatively correlated with Atopobium vaginae27, a frequently predominant microorganism in 
women with BV.
The novelty of our study consists of the in vivo demonstration that specific vaginal immune profiles signifi-
cantly correlate with the microbial composition and clinical manifestation. This finding may help in the diagnosis 
of BV, predict the recurrence of vaginal dysbiosis and help follow the recovery after treatment. We observed that 
a subset of pro-inflammatory mediators, typically involved in the chronic inflammation process, synergized with 
a subset of cytokines that are involved in the switch toward the Th2 immune response. This network likely sup-
ports a dysbiotic condition, regardless of the host pro-inflammatory Th1 response, which is normally effective at 
restoring the eubiosis state.
More precisely, the women with an intermediate Nugent Score showed a significant decrease in several 
pro-inflammatory cytokines, including IL328 and IL1713. This event, together with the poor T cell-stimulating 
activity of G. vaginalis29, which was predominant in the intermediate group, may explain the absence or weakness 
of clinical symptoms11. Moreover, B. breve, which was uniquely identified in the intermediate group, can induce 
Th1 polarization of lymphocytes30, supporting their own growth by the production of IL231 and determining the 
resistance toward the infections. This mechanism may support a biotic balance assuring a healthy vaginal milieu.
In women with vaginosis, a massive pro-inflammatory response was observed, supported by a significant 
increase of IL1832, a constituent of the inflammasome complex32. The increase in concentration of other compo-
nents of the inflammasome, such as IL1β, and the increase of several chemokines, such as IL8, MIG, MIP1α and 
RANTES, which are involved in the recruitment of leukocytes at the site of inflammation33, strongly differentiated 
women with vaginosis from women with an intermediate Nugent Score. This observation confirms the results of 
previous in vitro studies that showed an immunological shift towards a Th1-dominated profile during episodes 
of bacterial dysmicrobism34.
A new observation that emerged from our study is the significant association between specific commen-
sal microorganisms and the modulation of local cytokines and chemokines, some of which have never been 
described before. Specifically, IL5 and IL13, which are secreted by Th2 cells35 and are known to inhibit both the 
cell-mediated immune response and several macrophage functions, were statistically associated with Lactobacilli, 
Gardnerella and Ureaplasma species.
Based on the slight increase of these two cytokines (Table 5) and the depletion of some commensal bacteria 
(Fig. 1) in women with dysmicrobism, we suggest that the Th2 response is maintained at a steady state level of 
activation alongside the host Th1 response. The increase of the two anti-inflammatory cytokines is expected to 
significantly rise in asymptomatic women with an altered microbiome, explaining the absence or the weakness 
of symptoms. Furthermore, the steady-state Th2 response, together with a blunted Th1 response, could lead to 
immunologic tolerance causing chronic recurrent vaginal dysbiosis36.
Since IL5 and IL13 are strongly influenced by the alteration of eubiotic conditions, regardless of the specific 
pathogens causing the alteration of vaginal milieu, they could be further studied as indirect markers of vaginal 
disorder.
Taken together, our findings provide new in vivo insights into how different commensal bacterial species 
preserve the vaginal symbiotic equilibrium through their interplay with specific local immune mediators. These 
results raise clinically relevant questions regarding the role of vaginal immunological markers as crucial tool of 
surveillance of microbial alteration.
Methods
Patients and samples. Sixty-two immunocompetent women who fulfilled the inclusion eligibility criteria 
were included in this study. All women were Caucasian, of reproductive age (32–40 years old), were not pregnant, 
had no current use of hormonal or barrier contraceptive products, vaginal douching, tobacco or alcohol abuse, 
were not hospitalized or had systemic use of medication for chronic diseases or antibiotics/probiotics (oral or 
Healthy Intermediate Vaginosis
Healthy vs 
Intermediate
Healthy vs 
Vaginosis
Intermediate vs 
Vaginosis
IL5 0.29 ± 0.02 0.29 ± 0.04 0.35 ± 0.08 0.686 0.999 0.999
IL13 0.82 ± 0.06 0.75 ± 0.07 1 ± 0.19 0.592 0.999 0.580
Table 5. Soluble immune factors related to changes of the microbial composition. Data are shown as the mean 
value (pg/mL) ± standard error of mean. Comparisons between groups were performed using a nonparametric 
Kruskal-Wallis test. The p values are adjusted for multiple comparisons.
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topical) within the 6 months prior to sample collection, and had no intercourse in the day prior to sampling. 
Microbiological criteria excluded concomitantly sexually transmitted viral infections, including HSV I-II and 
HPV.
We identified patients among women that attended the Gynaecology Service of the Institute for Mother and 
Child Health IRCCS Burlo Garofolo of Trieste, Italy, as outpatients.
According to Nugent’s criteria, 17 women were diagnosed with bacterial vaginosis (Vaginosis, score 7–10) and 
15 with an intermediate dysbiotic status (Intermediate, score 4–6) while the remaining 30 women were diagnosed 
as healthy (score 0–3).
Vaginal samples were collected 7 days before the first day of the menstrual period. Under speculum examina-
tion, samples were collected using a 200 mm polyethylene Cervex brush device37 (Rovers Medical Devices B.V., 
The Netherlands) by a single gentle 360° rotation of the cytobrush at the cervical os and were suspended in 1.5 ml 
of TE buffer. Each sample was divided into 3 (500 µl) aliquots and stored at −80 °C.
Sample processing and Ion Torrent Sequencing. DNA extraction was carried out using the 
NucliSENS® easyMAG® system (BioMèrieux, Gorman, North Carolina, USA) with an elution volume of 50 µl. 
All DNA samples were stored at −80 °C prior to further processing.
A real time EvaGreen PCR (EvaGreen® dye, Fisher Molecular Biology, Waltham, USA) was performed with 
the degenerate primer 27FYM (5′-AGR GTT YGA TYM TGG CTC AG-3′) and the primer U534R, targeting the 
V1-V3 region (500 bp) to allow for the construction of rich libraries. A nested PCR, targeting the V3 region38, was 
performed with the primers B338F_P1-adaptor (B338F 5′-ACTCCTACGGGAGGCAGC-3′) and U534R_A_bar-
code (U534R 5′-ATTACCGCGGCTGCTGG-3′) in conjunction with the IonXpress Barcode Adapter to obtain 
the 200 bp V3 region template for sequencing analysis39. Negative controls, including a no template control, 
were processed with the clinical samples. The PCR reactions were performed using the Kapa 2 G HiFi Hotstart 
ready mix 2 × (Kapa Biosystems, Massachusetts, USA), which has robust amplification that is necessary for NGS 
sequencing40,41, and 400 ng/µL BSA, with the following temperature cycling conditions: 5 min at 95 °C, 30 sec at 
95 °C, 30 sec at 59°/57 °C, 45 sec at 72 °C and a final elongation step at 72 °C for 10 min.
Quantification of dsDNA was assessed with a Qubit® 2.0 Fluorometer (Invitrogen, Carlsbad, California, USA) 
and the pooled-library was diluted to a concentration of 100 pM.
Template preparation was performed using the Ion PGM Hi-Q View kit on the Ion OneTouch™ 2 System (Life 
Technologies, Gran Island, New York, USA) and sequenced using the Ion PGM Hi-Q View sequencing kit (Life 
Technologies, New York, USA) with the Ion PGM™ System technology.
Data Analysis. QIIME 1.8.0142 was used to process the sequence data. High quality (Q > 20) sequences 
were demultiplexed and filtered by quality using split_libraries_fastq.py with the default parameters, except for 
the length parameter (at least 150 bp). Operational taxonomic units (OTUs) were defined at 97% similarity and 
clustered against the Vaginal 16S rRNA gene Reference Database, which was constructed by Fettweis et al.43, 
using open-reference OTU picking44 with a uclust clustering tool45. Prior to further analysis, singleton OTUs 
and samples with low sequencing depth were removed (less than 10,000 reads). Chao1, PD whole tree, Shannon, 
Observed species and Simpson reciprocal metrics were used to assess alpha diversity (within-sample diversity), 
while beta diversity (between sample diversity comparison) was assessed with weighted and unweighted UniFrac 
distance matrices46,47 and presented with principal coordinates analysis (PCoA). The robustness of the identified 
clusters was investigated using jackknifing (randomly resampling sequences without replacement). Differences in 
community composition between cohorts were investigated using analysis of similarity (ANOSIM, 999 permuta-
tions) and Kruskal-Wallis test, implemented in QIIME.
Correlations between the immune mediators, for which normalized amounts were written in the mapping file, 
and both weighted and unweighted UniFrac distance matrices (generated from the beta_diversity.py script) were 
assessed by the compare_categories.py script (metric BIOENV) of QIIME, exploiting the Spearman rank-order 
coefficient. A Spearman coefficient close to 1 signifies a highly positive correlation between immune mediators 
and the distance matrices; a value close to 0 signifies no association; and a value approaching -1 signifies a highly 
negative correlation.
To survey the association between microbial identities and the increase or decrease of specific immune factors, 
the observation_metadata_correlation.py script (with the Fisher_z_transform p-value assignment) of QIIME was 
used. The otu_table_biom was rarefied to a depth of 10,000 sequences/sample and the normalized amounts of the 
immune markers were written in the mapping file.
The dataset was deposited in the SRA database (PRJNA361297).
Immune soluble factor quantification. The quantification of soluble immune factors was performed 
using a recently described platform that is based on a magnetic bead multiplex immunoassay (Luminex, Bio-Plex, 
BIO-RAD Laboratories, Milano, Italy), which simultaneously detects 48 analytes, including cytokines, chemok-
ines and growth factors48.
Briefly, 50 μL of biological samples and standards were added in duplicate into a 96 multiwell plate containing 
the analyte beads. After incubation for 30 minutes at room temperature and washing, the antibody-biotin reporter 
was added and incubated for 10 minutes with streptavidin-phycoerythrin. The concentrations of the cytokines 
were determined using the Bio-Plex array reader (Luminex, Austin, TX). The Bio-Plex Manager software opti-
mized the standard curves automatically and returned the data as Median Fluorescence Intensity (MFI) and 
concentration (pg/mL). To normalize the results, the total protein concentrations of samples were determined 
using a Bradford assay (Sigma-Aldrich, St. Louis, MO). Next, all cytokine and chemokine concentrations were 
normalized to total protein in the sample and were expressed as pg of immune marker⁄mL of total protein.
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Stata (v. 13.1) and GraphPad Prism (v. 5) were used for statistical data analysis. The Kruskal-Wallis one-way 
analysis of variance was used for comparisons between groups. When a significant p-value was observed 
(p < 0.05), a multiple comparison test was used to determine which groups were different.
Accession Codes. Sequences have been deposited at NCBI under the accessions PRJNA361297.
Ethics approval and consent to participate. The protocol used in this study was approved by the Ethics 
Committee of the IRCCS Burlo Garofolo Institute, Trieste (RC 26/13). All participants provided written informed 
consent for the experiments involving human participants and gave permission to access their medical records. 
All experiments were performed in accordance with the Declaration of Helsinki.
References
 1. Srinivasan, S. & Fredricks, D. N. The human vaginal bacterial biota and bacterial vaginosis. Interdisciplinary perspectives on infectious 
diseases 2008, 750479, https://doi.org/10.1155/2008/750479 (2008).
 2. Brotman, R. M. Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective. The Journal of clinical 
investigation 121, 4610–4617, https://doi.org/10.1172/JCI57172 (2011).
 3. Gillet, E. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis. BMC 
infectious diseases 11, 10, https://doi.org/10.1186/1471-2334-11-10 (2011).
 4. Nardis, C., Mosca, L. & Mastromarino, P. Vaginal microbiota and viral sexually transmitted diseases. Annali di igiene: medicina 
preventiva e di comunita 25, 443–456, https://doi.org/10.7416/ai.2013.1946 (2013).
 5. Gosmann, C. et al. Lactobacillus-Deficient Cervicovaginal Bacterial Communities Are Associated with Increased HIV Acquisition 
in Young South African Women. Immunity, https://doi.org/10.1016/j.immuni.2016.12.013 (2017).
 6. Fredricks, D. N., Fiedler, T. L. & Marrazzo, J. M. Molecular identification of bacteria associated with bacterial vaginosis. The New 
England journal of medicine 353, 1899–1911, https://doi.org/10.1056/NEJMoa043802 (2005).
 7. Lamont, R. F. et al. The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG: an 
international journal of obstetrics and gynaecology 118, 533–549, https://doi.org/10.1111/j.1471-0528.2010.02840.x (2011).
 8. Hedges, S. R., Barrientes, F., Desmond, R. A. & Schwebke, J. R. Local and systemic cytokine levels in relation to changes in vaginal 
flora. The Journal of infectious diseases 193, 556–562, https://doi.org/10.1086/499824 (2006).
 9. Livengood, C. H. Bacterial vaginosis: an overview for 2009. Reviews in obstetrics & gynecology 2, 28–37 (2009).
 10. Eschenbach, D. A. Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clinical infectious diseases: an official 
publication of the Infectious Diseases Society of America 16(Suppl 4), S282–287 (1993).
 11. Ling, Z. et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC genomics 11, 488, 
https://doi.org/10.1186/1471-2164-11-488 (2010).
 12. Srinivasan, S. et al. Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal 
relationships of microbiota to clinical criteria. PloS one 7, e37818, https://doi.org/10.1371/journal.pone.0037818 (2012).
 13. Gardner, H. L. & Dukes, C. D. Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific 
vaginitis. American journal of obstetrics and gynecology 69, 962–976 (1955).
 14. Borges, S., Silva, J. & Teixeira, P. The role of lactobacilli and probiotics in maintaining vaginal health. Archives of gynecology and 
obstetrics 289, 479–489, https://doi.org/10.1007/s00404-013-3064-9 (2014).
 15. Forney, L. J., Foster, J. A. & Ledger, W. The vaginal flora of healthy women is not always dominated by Lactobacillus species. The 
Journal of infectious diseases 194, 1468-1469; author reply 1469–1470, https://doi.org/10.1086/508497 (2006).
 16. Oh, J. E. et al. Dysbiosis-induced IL-33 contributes to impaired antiviral immunity in the genital mucosa. Proceedings of the National 
Academy of Sciences of the United States of America 113, E762–771, https://doi.org/10.1073/pnas.1518589113 (2016).
 17. Schwebke, J. R. Asymptomatic bacterial vaginosis: response to therapy. American journal of obstetrics and gynecology 183, 
1434–1439, https://doi.org/10.1067/mob.2000.107735 (2000).
 18. Swidsinski, A. et al. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecologic and obstetric 
investigation 70, 256–263, https://doi.org/10.1159/000314015 (2010).
 19. Swidsinski, A. et al. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PloS one 8, e53997, https://
doi.org/10.1371/journal.pone.0053997 (2013).
 20. Wertz, J., Isaacs-Cosgrove, N., Holzman, C. & Marsh, T. L. Temporal Shifts in Microbial Communities in Nonpregnant African-
American Women with and without Bacterial Vaginosis. Interdisciplinary perspectives on infectious diseases 2008, 181253, https://
doi.org/10.1155/2008/181253 (2008).
 21. Wasiela, M., Krzeminski, Z., Kalinka, J. & Brzezinska-Blaszczyk, E. [Correlation between levels of selected cytokines in cervico-
vaginal fluid of women with abnormal vaginal bacterial flora]. Medycyna doswiadczalna i mikrobiologia 57, 327–333 (2005).
 22. Kremleva, E. A. & Cherkasov, S. V. [Production of cytokines by vaginal epitheliocytes in the process of interaction with dominant 
and associative microsymbionts]. Zhurnal mikrobiologii, epidemiologii, i immunobiologii, 114–118 (2012).
 23. Hickey, R. J., Zhou, X., Pierson, J. D., Ravel, J. & Forney, L. J. Understanding vaginal microbiome complexity from an ecological 
perspective. Translational research: the journal of laboratory and clinical medicine 160, 267–282, https://doi.org/10.1016/j.
trsl.2012.02.008 (2012).
 24. Mayo, B., van Sinderen, D. & Ventura, M. Genome analysis of food grade lactic Acid-producing bacteria: from basics to applications. 
Current genomics 9, 169–183, https://doi.org/10.2174/138920208784340731 (2008).
 25. Breshears, L. M., Edwards, V. L., Ravel, J. & Peterson, M. L. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and 
Neisseria gonorrhoeae on a porcine vaginal mucosa model. BMC microbiology 15, 276, https://doi.org/10.1186/s12866-015-0608-0 
(2015).
 26. Aroutcheva, A. A., Simoes, J. A. & Faro, S. Antimicrobial protein produced by vaginal Lactobacillus acidophilus that inhibits 
Gardnerella vaginalis. Infectious diseases in obstetrics and gynecology 9, 33–39, https://doi.org/10.1155/S1064744901000060 (2001).
 27. De Backer, E. et al. Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and 
Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC microbiology 7, 115, https://doi.
org/10.1186/1471-2180-7-115 (2007).
 28. Vitali, B. et al. Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, 
analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Applied and environmental microbiology 73, 
5731–5741, https://doi.org/10.1128/AEM.01251-07 (2007).
 29. Bertran, T. et al. Slight Pro-Inflammatory Immunomodulation Properties of Dendritic Cells by Gardnerella vaginalis: The “Invisible 
Man” of Bacterial Vaginosis? Journal of immunology research 2016, 9747480, https://doi.org/10.1155/2016/9747480 (2016).
 30. Sanchez, B. et al. The effects of Bifidobacterium breve on immune mediators and proteome of HT29 cells monolayers. BioMed 
research international 2015, 479140, https://doi.org/10.1155/2015/479140 (2015).
 31. Liao, W., Lin, J. X. & Leonard, W. J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper 
cell differentiation. Current opinion in immunology 23, 598–604, https://doi.org/10.1016/j.coi.2011.08.003 (2011).
www.nature.com/scientificreports/
9SCIenTIfIC REpoRTS |  (2018) 8:2307  | DOI:10.1038/s41598-018-20649-x
 32. Nascimento, F. S. et al. Evaluation of library preparation methods for Illumina next generation sequencing of small amounts of DNA 
from foodborne parasites. Journal of microbiological methods 130, 23–26, https://doi.org/10.1016/j.mimet.2016.08.020 (2016).
 33. Engelhardt, E. et al. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during 
phase-specific infiltration of leukocyte subsets in human wound healing. The American journal of pathology 153, 1849–1860 (1998).
 34. Libby, E. K., Pascal, K. E., Mordechai, E., Adelson, M. E. & Trama, J. P. Atopobium vaginae triggers an innate immune response in 
an in vitro model of bacterial vaginosis. Microbes and infection 10, 439–446, https://doi.org/10.1016/j.micinf.2008.01.004 (2008).
 35. Tomasiak-Lozowska, M. M., Bodzenta-Lukaszyk, A., Tomasiak, M., Skiepko, R. & Zietkowski, Z. The role of interleukin 13 and 
interleukin 5 in asthma. Postepy Hig Med Dosw (Online) 64, 146–155 (2010).
 36. Miller, R. L., Tomai, M. A., Harrison, C. J. & Bernstein, D. I. Immunomodulation as a treatment strategy for genital herpes: review 
of the evidence. International immunopharmacology 2, 443–451 (2002).
 37. Mitra, A. et al. Comparison of vaginal microbiota sampling techniques: cytobrush versus swab. Scientific reports 7, 9802, https://doi.
org/10.1038/s41598-017-09844-4 (2017).
 38. Chakravorty, S., Helb, D., Burday, M., Connell, N. & Alland, D. A detailed analysis of 16S ribosomal RNA gene segments for the 
diagnosis of pathogenic bacteria. Journal of microbiological methods 69, 330–339, https://doi.org/10.1016/j.mimet.2007.02.005 
(2007).
 39. Sundquist, A. et al. Bacterial flora-typing with targeted, chip-based Pyrosequencing. BMC microbiology 7, 108, https://doi.
org/10.1186/1471-2180-7-108 (2007).
 40. van Dijk, E. L., Jaszczyszyn, Y. & Thermes, C. Library preparation methods for next-generation sequencing: tone down the bias. 
Experimental cell research 322, 12–20, https://doi.org/10.1016/j.yexcr.2014.01.008 (2014).
 41. Quail, M. A. et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina 
MiSeq sequencers. BMC genomics 13, 341, https://doi.org/10.1186/1471-2164-13-341 (2012).
 42. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nature methods 7, 335–336, https://
doi.org/10.1038/nmeth.f.303 (2010).
 43. Fettweis, J. M. et al. Species-level classification of the vaginal microbiome. BMC genomics 13(Suppl 8), S17, https://doi.
org/10.1186/1471-2164-13-S8-S17 (2012).
 44. Rideout, J. R. et al. Subsampled open-reference clustering creates consistent, comprehensive OTU definitions and scales to billions 
of sequences. PeerJ 2, e545, https://doi.org/10.7717/peerj.545 (2014).
 45. Edgar, R. C. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26, 2460–2461, https://doi.org/10.1093/
bioinformatics/btq461 (2010).
 46. Lozupone, C., Hamady, M. & Knight, R. UniFrac–an online tool for comparing microbial community diversity in a phylogenetic 
context. BMC bioinformatics 7, 371, https://doi.org/10.1186/1471-2105-7-371 (2006).
 47. Lozupone, C. & Knight, R. UniFrac: a new phylogenetic method for comparing microbial communities. Applied and environmental 
microbiology 71, 8228–8235, https://doi.org/10.1128/AEM.71.12.8228-8235.2005 (2005).
 48. Zanotta, N. et al. Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High 
Expression of Chemokines Promoting Angiogenesis and Cell Proliferation. PloS one 11, e0151851, https://doi.org/10.1371/journal.
pone.0151851 (2016).
Acknowledgements
This work was financially supported by the grant RC 26/13, IRCCS Burlo Garofolo Institute.
Author Contributions
Conceptualization, M.C.; Methodology, G.C. and N.Z.; Software, G.C. and D.L.; Investigation, G.C. and N.Z. 
F.D.S; Resources, F.D.S.; Data Curation, G.C. and N.Z.; Writing - Original Draft, G.C. and M.C.; Writing – Review 
& Editing M.C.; Visualization, G.C.; Funding Acquisition, M.C.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
